Loading…
Lunai Bioworks Inc. is projected to rise to $3.81 by 2027, a +45% move from its current price of $2.62. LNAI is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $2.40 | $2.62 | $2.87 | +0.01% |
| May 30 | $2.31 | $2.62 | $2.98 | +0.01% |
| May 31 | $2.24 | $2.62 | $3.06 | +0.02% |
| Jun 1 | $2.19 | $2.62 | $3.14 | +0.03% |
| Jun 2 | $2.14 | $2.62 | $3.20 | +0.03% |
| Jun 3 | $2.10 | $2.62 | $3.27 | +0.04% |
| Jun 4 | $2.07 | $2.62 | $3.32 | +0.05% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.07 | $2.62 | $3.32 | +0.05% |
| Week 2 | $1.87 | $2.62 | $3.67 | +0.10% |
| Week 3 | $1.74 | $2.62 | $3.96 | +0.15% |
| Week 4 | $1.63 | $2.63 | $4.22 | +0.20% |
| Week 5 | $1.54 | $2.63 | $4.47 | +0.24% |
| Week 6 | $1.47 | $2.63 | $4.70 | +0.29% |
| Week 7 | $1.40 | $2.63 | $4.93 | +0.34% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Lunai Bioworks Inc. is a pre-clinical stage biotechnology company that provides medicine, diagnostics, and biodefense products in the United States and the Netherlands. It operates through three segments, RENB, BioSymetrics, and RENC.
The company is developing a genetically modified allogeneic dendritic cell therapeutic vaccines, including RENB-DC11 to treat solid tumors primarily for pancreatic tumors; and RENB-DC20 for the treatment of breast cancer. It also develops an artificial intelligence platform technology for early cancer detection and its recurrence that uses a multi-omics approach to search for individual biomarkers that are present even in asymptomatic patients. The company was formerly known as Renovaro Inc.
and changed its name to Lunai Bioworks Inc. in August 2025. Lunai Bioworks Inc. is headquartered in Los Angeles, California.
Lunai Bioworks Inc. trades under the symbol LNAI and sits in the Healthcare category. Its current price is $2.62 with a market capitalization of $11.88M, and it ranks at 5047 by market position.
The near-term technical setup shows a neutral stance, with RSI14 at 50, a SMA50 of $2.76, and a SMA200 of $7.82. Immediate support is at $1.80 and resistance at $2.79. The 30-day price range runs from $1.45 to $4.74, and annualized volatility stands at 200%.
These pieces together portray a small-cap biotechnology asset with pronounced volatility but a cautious near-term outlook.
A major floor 46.2% below — a decisive break under it would weaken the trend.
The nearest floor, 31.3% below — buyers have tended to step in here.
The nearest ceiling, 6.6% above — a clean break opens room to run.
A major ceiling 223.7% above — clearing it would confirm fresh momentum.
Key LNAI support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of LNAI market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.22 | Buy | $2.31 | Buy |
| MA 10 | $2.18 | Buy | $2.28 | Buy |
| MA 20 | $2.38 | Buy | $2.37 | Buy |
| MA 50 | $2.76 | Sell | $2.86 | Sell |
| MA 100 | $4.03 | Sell | $4.52 | Sell |
| MA 200 | $7.81 | Sell | $11.43 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 53.54 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 69.52 | Neutral |
| Williams %R (14) | -5.08 | Info |
| MACD (12,26,9) | 0.03 | Buy |
| ROC (12) | -0.76 | Sell |
| Bollinger %B (20,2) | 0.73 | Neutral |
| Stochastic %K (14) | 94.92 | Sell |
| TRIX (15) | -0.91 | Sell |
| Awesome (5,34) | -0.29 | Sell |
| Ultimate (7,14,28) | 61.76 | Neutral |
| Momentum (10) | 0.11 | Buy |
| Aroon Osc (25) | -64.00 | Sell |
| Hull MA (9) | 2.36 | Buy |
| ADX (14) | 14.31 | Neutral |
| ATR (14) | 0.19 | Info |
The 30-day picture reflects a neutral market tone, with the RSI at 50 and price action hovering around the 50-day moving average of $2.76. Price momentum is muted as the asset sits between support and resistance in the $1.80–$2.79 zone. The stock has traded within a wide 30-day range of $1.45 to $4.74, underscoring elevated volatility.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.47 | $2.62 | $4.19 | 0% | Neutral | |
| $2.74 | $3.81 | $5.72 | +45% | Bullish | |
| $2.45 | $3.62 | $5.78 | +38% | Bullish | |
| $2.60 | $4.03 | $6.76 | +54% | Bullish | |
| $2.21 | $3.59 | $6.25 | +37% | Bullish | |
| $1.72 | $2.92 | $5.26 | +11% | Neutral | |
| $1.87 | $3.32 | $6.16 | +27% | Bullish | |
| $2.29 | $4.23 | $8.09 | +62% | Bullish | |
| $2.63 | $5.06 | $9.90 | +93% | Bullish | |
| $2.43 | $4.86 | $9.73 | +85% | Bullish | |
| $2.87 | $6.37 | $14.01 | +143% | Bullish | |
| $3.83 | $8.51 | $19.57 | +225% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.47 | $2.62 | $3.14 | +0.00% |
| June 2026 | $2.30 | $2.76 | $3.43 | +5.44% |
| July 2026 | $2.16 | $2.64 | $3.36 | -4.55% |
| August 2026 | $2.20 | $2.72 | $3.53 | +3.07% |
| September 2026 | $2.42 | $3.03 | $3.99 | +11.39% |
| October 2026 | $2.44 | $3.08 | $4.12 | +1.63% |
| November 2026 | $2.31 | $2.95 | $3.99 | -4.17% |
| December 2026 | $2.38 | $3.06 | $4.19 | +3.74% |
Click any year to see its month-by-month LNAI forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, LNAI is projected to trade between $1.47 and $4.19, averaging $2.62 — a potential gain of 0% from today's $2.62. A consolidation phase looks the most probable path here.
Lunai Bioworks Inc.'s 2027 outlook centres on $3.81, within a $2.74 to $5.72 range. That is up +45% on the projected 2026 average. That marks a +45% change versus current levels. Momentum favours further upside here.
By 2028, LNAI could reach as high as $5.78, with a base case around $3.62 and support toward $2.45 — roughly +38% from $2.62. Buyers look set to stay in control over this stretch.
Expect LNAI to range from $2.60 to $6.76 through 2029. The $4.03 average target implies a +54% move from current prices. That is up +11% on the projected 2028 average. Momentum favours further upside here.
The LNAI price prediction for 2030 points to an average of $3.59 (low $2.21, high $6.25) — a potential gain of +37% on today's $2.62. Buyers look set to stay in control over this stretch.
In 2031, LNAI is projected to trade between $1.72 and $5.26, averaging $2.92 — a potential gain of +11% from today's $2.62. That is -19% versus the projected 2030 average. Price action looks broadly range-bound.
Lunai Bioworks Inc.'s 2032 outlook centres on $3.32, within a $1.87 to $6.16 range. That is up +14% on the projected 2031 average. That marks a +27% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, LNAI could reach as high as $8.09, with a base case around $4.23 and support toward $2.29 — roughly +62% from $2.62. Momentum favours further upside here.
Expect LNAI to range from $2.63 to $9.90 through 2034. The $5.06 average target implies a +93% move from current prices. That is up +19% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The LNAI price prediction for 2035 points to an average of $4.86 (low $2.43, high $9.73) — a potential gain of +85% on today's $2.62. Momentum favours further upside here.
In 2040, LNAI is projected to trade between $2.87 and $14.01, averaging $6.37 — a potential gain of +143% from today's $2.62. That is up +31% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Lunai Bioworks Inc.'s 2050 outlook centres on $8.51, within a $3.83 to $19.57 range. That is up +34% on the projected 2040 average. That marks a +225% change versus current levels. Momentum favours further upside here.
Investing $1,000 in LNAI today (≈ 381.679389 LNAI) could be worth
$3,247.03
+$2,247.03 (+225%) by 2050 · US Dollar
Based on the average projected LNAI price of $8.51 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in LNAIwould be worth at today's price.
$1,000 invested in LNAI on May 27, 2025 (≈ 39.062499 LNAI) would be worth
$102.34
-$897.66 (-89.8%) today · 0.10× · US Dollar
Based on a LNAI entry price of $25.6 vs. today's $2.62.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.8 | $1,457.5 | +45.7% |
| 1 month ago | $2.47 | $1,061.24 | +6.1% |
| 3 months ago | $3.2 | $818.75 | -18.1% |
| 6 months ago | $9.44 | $277.54 | -72.2% |
| 1 year ago | $25.6 | $102.34 | -89.8% |
| All time (5.0y) ago | $332 | $7.89 | -99.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our LNAI forecast.
Our base-case forecast reaches $5.20 around 2040.
Implied market cap at $5.20: $23.58M
The year-by-year forecast paints a bullish longer-term path with varied upside. For 2026 the min is $1.47, the avg is $2.62, the max is $4.19, ROI 0, and sentiment NEUTRAL. In 2027 the min is $2.74, the avg is $3.81, the max is $5.72, ROI 45.3, sentiment BULLISH, followed by 2028 with min $2.45, avg $3.62, max $5.78, ROI 38.1, sentiment BULLISH, and 2029 with min $2.60, avg $4.03, max $6.76, ROI 53.9, sentiment BULLISH.
The 2030 forecast shows min $2.21, avg $3.59, max $6.25, ROI 36.9, sentiment BULLISH, while 2031 has min $1.72, avg $2.92, max $5.26, ROI 11.3, sentiment NEUTRAL. The 2032 outlook is min $1.87, avg $3.32, max $6.16, ROI 26.6, sentiment BULLISH, and 2033 is min $2.29, avg $4.23, max $8.09, ROI 61.6, sentiment BULLISH. The 2034 forecast is min $2.63, avg $5.06, max $9.90, ROI 93, sentiment BULLISH, and 2035 shows min $2.43, avg $4.86, max $9.73, ROI 85.4, sentiment BULLISH.
The long horizon strengthens with 2040 at min $2.87, avg $6.37, max $14.01, ROI 143.2, sentiment BULLISH, and 2050 at min $3.83, avg $8.51, max $19.57, ROI 224.7, sentiment BULLISH. These are estimates, not guarantees, and should be considered alongside inherent investment risk.”,
Tap a question to reveal the answer.
2030 avg $3.59, with a min of $2.21 and a max of $6.25; ROI 36.9%. The sentiment is BULLISH.
The forecast shows several bullish years (e.g., 2027, 2028, 2029, 2032, 2033, 2034, 2035, 2040, 2050) with positive ROI figures, though 2026 is NEUTRAL and 2031 is NEUTRAL. These are estimates and not guarantees, so risk and uncertainty remain.
Yes, the forecasted max price reaches $9.90 in 2034 and $14.01 in 2040, with a later max of $19.57 in 2050. Reaching $10 would occur within this projected window according to the provided numbers.
Current price is $2.62 and market cap is $11.88M. The company ranks 5047 by market position.
For 2050 the min is $3.83, the avg is $8.51, the max is $19.57, with ROI 224.7 and sentiment BULLISH.
Lunai Bioworks Inc. Community Discussion
0Share your Lunai Bioworks Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.